Quick Answer
BIOMERICA INC reported Total Revenue of $5.31 million for fiscal year 2025.
BIOMERICA INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $5.31M -1.9% |
$5.42M +1.4% |
$5.34M -71.7% |
$18.87M +162.1% |
$7.20M +7.6% |
$6.69M +28.7% |
| Net Income | -$4.97M +16.8% |
-$5.98M +16.3% |
-$7.14M -57.6% |
-$4.53M +39.2% |
-$7.45M -218.3% |
-$2.34M +2.3% |
| Diluted EPS | -$2.16 +23.9% |
-$2.84 -468.0% |
-$0.50 -38.9% |
-$0.36 +41.9% |
-$0.62 -169.6% |
-$0.23 +11.5% |
| Total Assets | $5.95M -35.8% |
$9.25M -36.0% |
$14.45M +27.1% |
$11.37M -3.8% |
$11.82M -31.5% |
$17.26M +229.1% |
| Cash and Equivalents | $2.40M -42.5% |
$4.17M -57.1% |
$9.72M +64.3% |
$5.92M +40.9% |
$4.20M -51.4% |
$8.64M +1158.2% |
| Stockholders Equity | $4.11M -37.7% |
$6.59M -43.8% |
$11.72M +40.8% |
$8.32M -9.8% |
$9.23M -35.1% |
$14.21M +257.0% |
| R&D Expense | $1.02M -31.4% |
$1.49M -5.9% |
$1.58M -12.6% |
$1.81M -17.4% |
$2.19M +14.9% |
$1.91M +13.8% |
| Operating Income | -$5.14M +19.3% |
-$6.37M +11.9% |
-$7.22M -59.3% |
-$4.53M +39.5% |
-$7.50M -212.1% |
-$2.40M +0.4% |
| Gross Profit | $498.0K -18.5% |
$611.0K +37.0% |
$446.0K -85.0% |
$2.98M +712.8% |
$366.3K -79.4% |
$1.78M +37.9% |
| Shares Outstanding | 2.55M +21.1% |
2.10M -87.5% |
16.82M +30.7% |
12.87M +4.6% |
12.31M +4.8% |
11.74M +21.3% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | November 30, 2025 | $1.21M | -26.0% | -12.3% |
| Net Income | November 30, 2025 | -$1.32M | -38.9% | -66100.0% |
| Diluted EPS | November 30, 2025 | -$0.45 | -650.0% | — |
| Total Assets | November 30, 2025 | $6.03M | -17.0% | -12.0% |
| Cash and Equivalents | November 30, 2025 | $2.54M | +7.2% | -16.7% |
| Stockholders Equity | November 30, 2025 | $4.43M | -13.3% | -14.0% |
| R&D Expense | November 30, 2025 | $193.0K | -24.9% | -9.0% |
| Operating Income | November 30, 2025 | -$1.37M | -38.3% | -22.8% |
| Gross Profit | November 30, 2025 | $51.0K | -88.3% | -88.0% |
| Shares Outstanding | November 30, 2025 | 2.95M | -83.9% | +4.7% |
- BIOMERICA INC reported Total Revenue of $5.31 million for fiscal year 2025.
- BIOMERICA INC showed a decrease of -1.9% in Total Revenue compared to the prior fiscal year.
- BIOMERICA INC reported Net Income of -$4.97 million for fiscal year 2025.
- BIOMERICA INC showed an increase of +16.8% in Net Income compared to the prior fiscal year.
- BIOMERICA INC reported Diluted EPS of $2.16 per share (loss) for fiscal year 2025.
- BIOMERICA INC showed an increase of +23.9% in Diluted EPS compared to the prior fiscal year.
- BIOMERICA INC reported Total Assets of $5.95 million for fiscal year 2025.
- BIOMERICA INC showed a decrease of -35.8% in Total Assets compared to the prior fiscal year.
- BIOMERICA INC reported Cash and Equivalents of $2.40 million for fiscal year 2025.
- BIOMERICA INC showed a decrease of -42.5% in Cash and Equivalents compared to the prior fiscal year.
- BIOMERICA INC reported Stockholders Equity of $4.11 million for fiscal year 2025.
- BIOMERICA INC showed a decrease of -37.7% in Stockholders Equity compared to the prior fiscal year.
- BIOMERICA INC reported R&D Expense of $1.02 million for fiscal year 2025.
- BIOMERICA INC showed a decrease of -31.4% in R&D Expense compared to the prior fiscal year.
- BIOMERICA INC reported Operating Income of -$5.14 million for fiscal year 2025.
- BIOMERICA INC showed an increase of +19.3% in Operating Income compared to the prior fiscal year.
- BIOMERICA INC reported Gross Profit of $498.0 thousand for fiscal year 2025.
- BIOMERICA INC showed a decrease of -18.5% in Gross Profit compared to the prior fiscal year.
- BIOMERICA INC reported Shares Outstanding of 2.55 million shares for fiscal year 2025.
- BIOMERICA INC showed an increase of +21.1% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: